Pursuance of Retrospective eGFR study for Strategic Trial for the Prevention of Progression of Overt Diabetic Nephropathy

Pursuance of Retrospective eGFR study for Strategic Trial for the Prevention of Progression of Overt Diabetic Nephropathy - PRe-STOPPER study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000022602

Enrollment

10000

Registered

2016-06-04

Start date

2015-06-10

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes mellitus with/without neprhopathy

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Diabetic subjects who were cared and treated during a year in several medical center.

Exclusion criteria

Exclusion criteria: Less than 20 years old.

Design outcomes

Primary

Measure	Time frame
delta-eGFRslope0-1y during a year from the clinical data	—

Secondary

Measure	Time frame
Clinical data: HbA1c, UACR, UPCR, LDL-C, HDL-C, TG, sBP, dBP. Medications: for diabetes mellitus, hypertension and dyslipidemia. Certified diabetic education.	—

Countries

Japan

Contacts

Public ContactMasayuki Miuchi

Hyogo College of Medicine Division of Diabetes, Endocrinology and Metabolism, Department of Internal Medicine

masa-miu@hyo-med.ac.jp0798-45-6592

Outcome results